World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
78
Citations
21527
World Ranking
1284
National Ranking
73

Overview

Vincent Calvez is a researcher affiliated with the Centre national de la recherche scientifique (CNRS) in France. Their scholarly work primarily spans the field of Medicine, with a strong focus on Infectious Diseases, Epidemiology, Virology, Genetics, and Molecular Biology.

The scientist has contributed to research across several main topics including:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS Research and Interventions
  • COVID-19 Clinical Research Studies
  • Evolution and Genetic Dynamics
  • Viral-associated cancers and disorders

Frequent publication venues for Vincent Calvez include:

  • Journal of Antimicrobial Chemotherapy
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Infection
  • Clinical Infectious Diseases
  • Microbiology Spectrum

Notable recent papers authored or coauthored by Vincent Calvez are:

  • "2025 update of the drug resistance mutations in HIV-1," 2025, PubMed
  • "Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers," 2021, Nature Communications
  • "The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients," 2021, Journal of Infection
  • "Viral loads in clinical samples of men with monkeypox virus infection: a French case series," 2022, The Lancet Infectious Diseases
  • "Evolution of viral quasispecies during SARS-CoV-2 infection," 2020, Clinical Microbiology and Infection

Vincent Calvez has collaborated extensively with several frequent coauthors including Anne-Geneviève Marcelin, Stéphane Marot, Aude Jary, Cathia Soulié, and Marc Wirden. These collaborations reflect a multidisciplinary approach within infectious disease and virology research.

Best Publications

  • 2017 Update of the Drug Resistance Mutations in HIV-1.

    Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  • Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

    TS Li;R Tubiana;C Katlama;V Calvez

  • 2015 Update of the Drug Resistance Mutations in HIV-1.

    Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  • Mechanisms of Virologic Failure in Previously Untreated HIV-Infected Patients From a Trial of Induction-Maintenance Therapy

    D Descamps;P Flandre;V Calvez;G Peytavin

  • Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma.

    N. Dupin;M. Grandadam;V. Calvez;J.T. Aubin

  • Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

    Y Benhamou;M Bochet;V Thibault;V Calvez

  • Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro

    Isabelle Malet;Olivier Delelis;Marc-Antoine Valantin;Brigitte Montes

  • Update of the drug resistance mutations in HIV-1: March 2013.

    Victoria A Johnson;Vincent Calvez;Huldrych F Gunthard;Roger Paredes

  • Interactions between Atazanavir-Ritonavir and Tenofovir in Heavily Pretreated Human Immunodeficiency Virus-Infected Patients

    Anne-Marie Taburet;Christophe Piketty;Corine Chazallon;Isabelle Vincent

  • Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial

    Collins C Iwuji;Collins C Iwuji;Joanna Orne-Gliemann;Joseph Larmarange;Eric Balestre

  • Directional persistence of chemotactic bacteria in a traveling concentration wave

    Jonathan Saragosti;Vincent Calvez;Nikolaos Bournaveas;Benoît Perthame

  • HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment

    Avidan U. Neumann;Roland Tubiana;Vincent Calvez;Catherine Robert

  • Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Günthard;Vincent Calvez;Roger Paredes;Deenan Pillay

  • Depletion in blood CD11c-positive dendritic cells from HIV-infected patients.

    Fernanda Grassi;Anne Hosmalin;Dorian McIlroy;Vincent Calvez

  • Rituximab therapy for HIV-associated Castleman disease.

    Anne-Geneviève Marcelin;Laurent Aaron;Christine Mateus;Emmanuel Gyan

  • Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.

    Guislaine Carcelain;Roland Tubiana;Assia Samri;Vincent Calvez

  • Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-κB and MAPK pathways

    Philippe A. Grange;Joël Raingeaud;Vincent Calvez;Nicolas Dupin

  • Restoration of the immune system with anti-retroviral therapy.

    Brigitte Autran;Guislaine Carcelaint;Taisheng S. Li;Guy Gorochov

  • Exacerbations of Clinical Symptoms in Human Immunodeficiency Virus Type 1—Infected Patients with Multicentric Castleman's Disease Are Associated with a High Increase in Kaposi's Sarcoma Herpesvirus DNA Load in Peripheral Blood Mononuclear Cells

    Marc Grandadam;Nicolas Dupin;Vincent Calvez;Isabelle Gorin

  • Diagnosing Treponema pallidum in Secondary Syphilis by PCR and Immunohistochemistry

    Marc Buffet;Philippe A. Grange;Philippe Gerhardt;Agnès Carlotti

  • Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers.

    Stéphane Marot;Isabelle Malet;Valentin Leducq;Karen Zafilaza

  • Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.

    C. Delaugerre;R. Rohban;A. Simon;M. Mouroux

Frequent Co-Authors

Christine Katlama
Christine Katlama Sorbonne University
Gilles Peytavin
Gilles Peytavin Claude Bernard University Lyon 1
Nicolas Dupin
Nicolas Dupin Université Paris Cité
Constance Delaugerre
Constance Delaugerre Université Paris Cité
Henri Agut
Henri Agut Sorbonne University
Guislaine Carcelain
Guislaine Carcelain Université Paris Cité
Brigitte Autran
Brigitte Autran Sorbonne University
Benoît Perthame
Benoît Perthame Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various related fields with strong career potential. For example, pursuing a healthcare-related bachelor's degree can lead to roles like a child life specialist, where understanding biology and patient care is essential. To learn more about earning potential in this field, see the child life specialist salary with bachelor degree.

For those with unique challenges, such as felons looking to rebuild their careers, there are accessible options. Microbiology and allied health sciences can be part of the list of degrees felons can get, offering a meaningful path into science-based professions with flexible online learning opportunities.

Additionally, combining microbiology knowledge with nursing opens paths like becoming a functional medicine nurse practitioner. This role emphasizes holistic and evidence-based patient care, supported by a solid science background. For insight into the financial outlook, check the functional medicine nurse practitioner salary.

Beyond direct healthcare roles, certifications such as CPC (Certified Professional Coder) also complement microbiology studies by enhancing job prospects in medical billing and coding. This specialization offers competitive earning potential as outlined in the cpc certification salary overview.

Best Scientists Citing Vincent Calvez

Trending Scientists

Recently Published Articles